Loading...
Azenta, Inc.
AZTA•NASDAQ
Healthcare
Medical - Instruments & Supplies
$34.43
$0.47(1.38%)
Azenta, Inc. (AZTA) Financial Performance & Income Statement Overview
Review Azenta, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.32%
↓ 1.32%
Operating Income Growth
-174.43%
↓ 174.43%
Net Income Growth
-1051.50%
↓ 1051.50%
Operating Cash Flow Growth
187.53%
↑ 187.53%
Operating Margin
-8.18%
↓ 8.18%
Gross Margin
43.08%
↑ 43.08%
Net Profit Margin
-10.31%
↓ 10.31%
ROE
-3.64%
↓ 3.64%
ROIC
-2.85%
↓ 2.85%
Azenta, Inc. (AZTA) Income Statement & Financial Overview
Review Azenta, Inc.'s (AZTA) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $147.51M | $170.06M | $172.81M | $159.13M |
| Cost of Revenue | $78.84M | $100.65M | $103.75M | $102.40M |
| Gross Profit | $68.67M | $69.41M | $69.06M | $56.73M |
| Gross Profit Ratio | $0.47 | $0.41 | $0.40 | $0.36 |
| R&D Expenses | $6.38M | $8.41M | $7.91M | $8.71M |
| SG&A Expenses | $73.21M | $72.01M | $73.83M | $71.66M |
| Operating Expenses | $79.59M | $81.71M | $83.81M | $80.37M |
| Total Costs & Expenses | $158.43M | $182.35M | $187.56M | $182.77M |
| Interest Income | $4.30M | $5.53M | $8.004M | $9.56M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.93M | $23.84M | $22.68M | $22.35M |
| EBITDA | -$9.42M | $13.42M | $12.65M | -$578000.00 |
| EBITDA Ratio | -$0.06 | $0.08 | $0.07 | -$0.004 |
| Operating Income | -$11.35M | -$12.29M | -$10.03M | -$23.64M |
| Operating Income Ratio | -$0.08 | -$0.07 | -$0.06 | -$0.15 |
| Other Income/Expenses (Net) | $5.50M | $5.05M | $3.002M | -$114.21M |
| Income Before Tax | -$5.85M | -$7.24M | -$7.03M | -$137.14M |
| Income Before Tax Ratio | -$0.04 | -$0.04 | -$0.04 | -$0.86 |
| Income Tax Expense | $3.57M | -$2.25M | -$450000.00 | -$260000.00 |
| Net Income | -$13.34M | -$4.98M | -$6.58M | -$136.88M |
| Net Income Ratio | -$0.09 | -$0.03 | -$0.04 | -$0.86 |
| EPS | -$0.29 | $0.00 | -$0.12 | -$2.47 |
| Diluted EPS | -$0.29 | $0.00 | -$0.12 | -$2.47 |
| Weighted Avg Shares Outstanding | $45.63M | $0.00 | $52.96M | $55.44M |
| Weighted Avg Shares Outstanding (Diluted) | $45.63M | $0.00 | $52.96M | $55.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan